so survival was 4 out of 19? For those saying there is enough clinical data out there. The article you posted suggests they are not even sure when to use cytosorb or if there is a benefit. However, they could have written a case report on the 1 of the 4 that did survive...you see how that works.
I am out for now. Will look to re-enter after there is clarity on the dosing study. Maybe I will miss a nice rise if results are positive, but just not comfortable enough with what is known at this time.
A firm commitment to run a large scale sepsis study would give me some confidence, but they are not giving that indication right now.
News 
Market Data 
Discover 
AI
